年龄和种族在乙型肝炎病毒感染的退伍军人肝细胞癌风险中的作用
该回顾性队列研究利用美国退伍军人事务部2001至2013年数据,纳入8329例慢性HBV感染者,分析种族和年龄对肝细胞癌风险的影响。亚太岛民年发病率最高(0.65%),其次为白人(0.57%)和非裔美国人(0.40%);调整后亚太岛民肝细胞癌风险显著高于白人(调整HR=2.04;95%CI,1.31-3.17),非裔美国人与白人无差异(调整HR,0.77;95%CI,0.58-1.02)。肝细胞癌风险随年龄增长而增加,肝硬化患者风险更高(调整HR=3.69;95%CI,2.82-4.83)。
要点
- 亚太岛民慢性HBV感染者肝细胞癌风险显著高于白人(调整HR=2.04;95%CI,1.31-3.17)。
- 肝细胞癌风险随年龄增长而增加,60岁以上者调整HR=4.02(95%CI,2.03-7.94)对比40岁以下者。
- 无肝硬化但年龄大于40岁且丙氨酸氨基转移酶升高的男性患者,无论种族,年发病率均超过0.2%。
核心结论
- 在慢性HBV感染的男性退伍军人样本中,肝细胞癌风险以亚太岛民最高,其次为白人和非裔美国人;肝硬化增加肝细胞癌风险;无肝硬化但年龄大于40岁且丙氨酸氨基转移酶升高的男性患者可能受益于肝细胞癌监测,无论种族。
研究设计与样本
- 回顾性队列研究,使用美国退伍军人事务部全国数据,纳入2001年至2013年慢性HBV感染患者8329例;白人3498例(42.0%),非裔美国人3248例(39%),亚太岛民659例(7.9%)。
主要发现
- 年肝细胞癌发病率以亚太岛民最高(0.65%),其次为白人(0.57%)和非裔美国人(0.40%)。
- 调整临床和病毒因素后,亚太岛民肝细胞癌风险显著高于白人(调整HR=2.04;95%CI,1.31-3.17)。
- 非裔美国人与白人之间肝细胞癌风险无差异(调整HR,0.77;95%CI,0.58-1.02)。
- 肝细胞癌风险随年龄增长而增加:40-49岁调整HR=1.97(95%CI,0.99-3.87);50-59岁调整HR=3.00(95%CI,1.55-5.81);60岁以上调整HR=4.02(95%CI,2.03-7.94),均对比40岁以下者。
- 肝硬化患者肝细胞癌风险高于无肝硬化患者(调整HR=3.69;95%CI,2.82-4.83);但即使无肝硬化,年龄大于40岁且丙氨酸氨基转移酶升高的所有患者年发病率均超过0.2%,无论种族。
临床怎么用
- 作者认为,无肝硬化的慢性HBV感染男性患者中,年龄大于40岁且丙氨酸氨基转移酶升高者可能受益于肝细胞癌监测,无论种族。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Hepatocellular (HCC) surveillance guidelines for patients with chronic hepatitis B virus (HBV) infection are based on race- and age-specific estimates of HCC risk, derived from studies conducted in areas in which HBV is endemic. METHODS: We conducted a retrospective cohort study using the national Veterans Administration data to identify patients with chronic HBV infection from 2001 through 2013. We examined the effect of race and age on HCC risk while adjusting for baseline clinical characteristics. RESULTS: The study cohort had 8329 patients; 3498 patients (42.0%) were white, 3248 (39%) were African Americans, and 659 (7.9%) were Asian Pacific Islanders. The annual HCC incidence was highest in Asian Pacific Islanders (0.65%), followed by whites (0.57%) and African Americans (0.40%). After adjusting for clinical and viral factors, the risk of HCC was significantly higher in Asian Pacific Islanders compared with whites (adjusted hazard ratio [HR] = 2.04; 95% CI, 1.31-3.17). There was no difference in HCC risk between African Americans and whites (adjusted HR, 0.77; 95% CI, 0.58-1.02). HCC risk increased with age: adjusted HR was 1.97 (95% CI, 0.99-3.87) for 40-49 years; adjusted HR was 3.00 (95% CI, 1.55-5.81) for 50-59 years; and adjusted HR was 4.02 (95% CI, 2.03-7.94) for more than 60 years vs less than 40 years. Patients with cirrhosis had higher risk of HCC than patients without cirrhosis (adjusted HR = 3.69; 95% CI, 2.82-4.83). However, even among patients without cirrhosis, the annual incidence of HCC was more than 0.2% for all patients older than 40 years with high levels of alanine aminotransferase-regardless of race. CONCLUSIONS: In a sample of male veterans with chronic HBV infection, risk of HCC is highest among Asian Pacific Islanders, followed by whites and African Americans. Cirrhosis increased HCC risk. Among patients without cirrhosis, male patients who are older than 40 years and have increased levels of alanine aminotransferase might benefit from HCC surveillance, regardless of race.
引用
- Mittal S, Kramer JR, Omino R, et al. Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection. Clin Gastroenterol Hepatol. 2017. PMID: 28870660. doi:10.1016/j.cgh.2017.08.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。